iKang Group Announces Partnership To Establish IBM Watson Oncology Centers in China
Jul 28, 2017 12:09 pm UTC| Business
BEIJING, July 28, 2017 -- iKang Healthcare Group, Inc. (“iKang” or the “Company”) (Nasdaq:KANG), a major provider in China’s fast-growing private preventive healthcare services market, has officially announced its...
iTeos Therapeutics Granted EUR 7.5 Million Non-Dilutive Funding by the Walloon Region
Jul 28, 2017 12:01 pm UTC| Business
iTeos Therapeutics Granted EUR 7.5 Million Non-Dilutive Funding by the Walloon Region Funding will support the clinical development of the Company's lead innovative immuno-oncology drug Gosselies, Belgium - July...
LoRaWAN-based Network Coverage with Semtech’s LoRa Technology Grows in China
Jul 28, 2017 12:01 pm UTC| Business
CAMARILLO, Calif., July 28, 2017 -- Semtech Corporation (Nasdaq:SMTC), a leading supplier of high performance analog and mixed-signal semiconductors and advanced algorithms, announced the expansion in China of a...
Jul 28, 2017 12:01 pm UTC| Business
- Pre-Conference symposium, posters, and oral presentation will highlight GEN-003 Phase 2b clinical data - CAMBRIDGE, Mass., July 28, 2017 -- Genocea Biosciences, Inc. (NASDAQ:GNCA), a biopharmaceutical company...
Silicon Motion Confirms Quarterly Dividend
Jul 28, 2017 12:01 pm UTC| Business
TAIPEI, Taiwan and MILPITAS, Calif., July 28, 2017 -- Silicon Motion Technology Corporation (NasdaqGS: SIMO) (“Silicon Motion” or the “Company”), a global leader in designing and marketing NAND flash controllers for...
CHF Solutions, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Jul 28, 2017 12:01 pm UTC| Business
EDEN PRAIRIE, Minn., July 28, 2017 -- CHF Solutions, Inc. (NASDAQ:CHFS), today announced that on July 25, 2017, the Compensation Committee of the Board of Directors approved two equity awards under CHF Solution’s...
Elite Announces Co-Development of Four Additional Products with SunGen Pharma
Jul 28, 2017 12:00 pm UTC| Business
NORTHVALE, N.J., July 28, 2017 -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB:ELTP), a specialty pharmaceutical company developing abuse-deterrent opioids and niche generic products, today announced...